Sarah Romano insider trades

Open-market stock purchases and sales by Sarah Romano, Chief Financial Officer at Entero Therapeutics, Inc, from SEC Form 4 filings since Feb 6, 2017.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • ENTO Entero Therapeutics, Inc: 3 sales, last Jan 6, 2025
  • FWBI First Wave BioPharma, Inc: 6 sales, last Apr 1, 2024
  • KPRX Kiora Pharmaceuticals Inc: other filings, last Feb 10, 2022
  • EYEG Eyegate Pharmaceuticals Inc: 3 buys, 3 sales, last Nov 2, 2021

Get free alerts when Sarah Romano files a new trade →